India's Dr. Lal PathLabs extends gains on Q4 profit jump
10/05/2024 09:35
** Shares of Dr. Lal PathLabs Ltd DLPA.NS up 6.6% at
2,379.60 rupees
** Medical diagnostics firm reports 49% jump in Q4
consolidated net profit, with revenue growing faster than
expenses
** Stock was up 4% ahead of results
** Around 570,000 shares traded, 2x 30-day avg volume
** Analysts covering DLPA rate it "hold" on avg,
same as Metropolis Healthcare METP.NS , vs "buy" for Vijaya
Diagnostic Centre VIJA.NS - LSEG data
** DLPA reduces YTD losses to under 8% but trails METP's 4%
rise and VIJA's 17% growth
(Reporting by Nandan Mandayam in Bengaluru)
((Nandan.Mandayam@thomsonreuters.com; Mobile: +91 9591011727;))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise